New approaches to symptomatic treatments for Alzheimer’s disease
Successful development of agents that improve cognition and behavior in Alzheimer’s disease (AD) is critical to improving the lives of patients manifesting the symptoms of this progressive disorder.
Citation: Molecular Neurodegeneration 2021 16:2